I am reaching out to inquire if anyone has had hypoglycemia events (ie, <70) with long acting insulins (Semglee) vs. other insulins?

If you have, have you been able to identify the root cause(s) of the hypoglycemia with this med? What have you done to reduce the incidence? Hypoglycemia is multifactorial, but seem to see more with long acting insulins vs. any others.

Your feedback is appreciated!!

Hi,

We recently started tracking our scanning compliance for our pharmacy carousel. This is a metric recommended on the current ASHP Medication Safety Dashboard toolkit and they provide a benchmark of 95%.

Does anyone have a medication management policy/procedure for addressing patient's clinical needs (i.e. can't meet need by med administration before or after program hours) in recurring encounters/visits in behavioral health/intensive outpatient programs for children and adolescents? Do you permit use of patient's own medications (POM)? If yes, how do you have the approved POM medication order carry across the multiple encounters? I'm in an Epic organization. Thank you in advance.

I'm interested in any look/sound alike or high-alert meds at your hospitals that aren't on the ISMP lists. Maybe ones that you've identified based on your error reports, etc.

One that I've been thinking about lately is our epi nasal solution that looks just like an inj vial.

Thanks

Good morning,
Does your organization have a strategy for how many IV pumps you keep on hand?
How did you come up with your number?

We are frequently running low on LVPs (we use Alaris) and we are trying to see if there are best practices for how many we should have on hand per patient, or maybe average daily census?
Would love to hear how you handle at your organization.
Best,
Stacie Ethington MSN, RN
Nebraska Medicine

Has anyone else seen increased rates of infiltration with ampicillin IV push doses?
we recently switched to IV push antibiotics in light of the shortage and our L&D dept has reported infiltration occurring in their patients who are on ampicillin.

They are running it on a syringe pump.

Most manufacturers of antiretroviral medications prohibit repackaging. They state that the included desiccant in the bottle protects against moisture, but there is no evidence to support potency loss or degradation.

Most institutions repackage medications for inpatient use, and for outpatient care, educators assist patients in filling their pill bottles, which technically counts as repackaging.

Inquiring to learn What is the appropriate action to take in this scenario to ensure patient safety and compliance?

Any feedback is greatly appreciated. Thank you.

After reviewing the 2022-2023 ISMP Guidelines for Medication Safety in Perioperative and Procedural Settings, we recently converted to the NRFit connectors for all our Epidural infusions.

If anyone is interested in learning more about NRFit connectors or our implementation details, there is an upcoming Webinar featuring these topics. Use the link below to register:

https://us06web.zoom.us/webinar/register/WN_eT2rU8OwSGiHzIE3ht2bjA#/regi...

We are doing some work on our vasopressor concentrations and was wondering what people's standard concentrations are for epinephrine, phenylephrine and norepinephrine? Do you follow the ASHP Standardize 4 Safety recommendations? Thanks

Hi Everyone!

I am the medication safety pharmacist at a rural hospital in California and we are looking to change/revamp our current Medication Error Reduction Plan (MERP) and medication error summary reports. Would anyone be open to sharing and/or discussing their current MERP and medication error reports templates?

While this is a requirement for California, ISMP has recommended that healthcare organizations use California's MERP as a model and results from a survey reinforce the impact this type of comprehensive strategic framework can have on prevention efforts.